Effects of Invisalign Palatal Expander System

Last updated: May 13, 2024
Sponsor: University of the Pacific
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

HE

IPE

Clinical Study ID

NCT06414863
2024-43
  • Ages 6-14
  • All Genders

Study Summary

The aim of this study is to evaluate the effectiveness of Invisalign Palatal Expander system ingrowing patients. This study compares the treatment outcomes of Invisalign Palatal Expander system to conventional treatments through randomized controlled trial.

Eligibility Criteria

Inclusion

Inclusion criteria:

  1. Mixed dentition phase with at least three nonmobile (stable) teeth which have morethan 1/4 of primary molar root length left16 in either side

  2. Early permanent dentition stage and early permanent dentition but second permanentmolars not yet fully erupted in the arch

  3. Unilateral or bilateral posterior cross bite patients; or Patients who have beendiagnosed with transverse maxillary deficiency (Skeletal transverse discrepancymeasured from the estimated center of resistances of the first molars17 ≤ - 3 mm);

  4. Patients with Class I or Class II skeletal relationship

  5. Subjects willing to consent to the trial

Exclusion

Exclusion Criteria:

  1. Any general medical health problems which may influence treatment

  2. Any craniofacial anomalies

  3. Skeletal Class III patients

  4. Mixed dentition patients with more than 2 heavily restored primary second orpermanent first molars.

Study Design

Total Participants: 120
Treatment Group(s): 2
Primary Treatment: HE
Phase:
Study Start date:
May 10, 2024
Estimated Completion Date:
May 10, 2034

Connect with a study center

  • University of the Pacific

    San Francisco, California 94103
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.